HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melatonin protects against transient focal cerebral ischemia in both reproductively active and estrogen-deficient female rats: the impact of circulating estrogen on its hormetic dose-response.

Abstract
Melatonin (5-15 mg/kg) protects male animals against ischemic stroke. We explored the potential interactions and synergistic neuroprotection of melatonin and estrogen using a panel of lipid peroxidation and radical-scavenging assays, primary neuronal cultures subjected to oxygen-glucose deprivation (OGD), and lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Neuroprotective efficacy of melatonin was also evaluated in both reproductively active and ovariectomized female rats subjected to transient focal cerebral ischemia. Relative to melatonin or estradiol (E2) alone, a combination of the two agents exhibited robust, synergistic antioxidant and radical-scavenging actions (P<0.05, respectively). Additionally, the two agents, when combined at large doses, showed synergistic inhibition in the production of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) in the LPS-stimulated RAW 264.7 cells (P<0.05, respectively). Alternatively, co-treatment with melatonin and E2 independently, but not combined, showed a U-shaped dose-responsive (hormetic) cytoprotection for neuronal cultures subjected to OGD. When combined at a dosage either positively or negatively skewed from each optimal dosage, however, co-treatment caused synergistic neuroprotection. Relative to vehicle-injected controls, melatonin given intravenously at 1-5 mg/kg, but not 0.1 or 15 mg/kg, significantly reduced brain infarction and improved neurobehavioral outcomes (P<0.05, respectively) in reproductively active female rats. In ovariectomized stroke rats, melatonin was only effective at a large dosage (15-50 mg/kg). These results demonstrate complex interactions and synergistic antioxidant, radical-scavenging, and anti-inflammatory actions between estradiol and melatonin, and highlight the potential need to rectify the melatonin's hormetic dose-response by the level of circulating estradiol in the treatment of female stroke patients.
AuthorsShih-Huang Tai, Yu-Chang Hung, E-Jian Lee, Ai-Chiang Lee, Tsung-Ying Chen, Chiung-Chyi Shen, Hung-Yi Chen, Ming-Yang Lee, Sheng-Yang Huang, Tian-Shung Wu
JournalJournal of pineal research (J Pineal Res) Vol. 50 Issue 3 Pg. 292-303 (Apr 2011) ISSN: 1600-079X [Electronic] England
PMID21210839 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 The Authors. Journal of Pineal Research © 2011 John Wiley & Sons A/S.
Chemical References
  • Estrogens
  • Interleukin-6
  • Nitrates
  • Nitrites
  • Tumor Necrosis Factor-alpha
  • Melatonin
Topics
  • Animals
  • Animals, Newborn
  • Body Weight (drug effects)
  • Cell Line
  • Cells, Cultured
  • Estrogens (deficiency, metabolism)
  • Female
  • Interleukin-6 (metabolism)
  • Ischemic Attack, Transient (drug therapy)
  • Lipid Peroxidation (drug effects)
  • Melatonin (therapeutic use)
  • Nitrates (metabolism)
  • Nitrites (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: